Catalyst Wire Dossier Catalyst Wire Dossier

Rhesoglobin (human anti-D immunoglobulin)

anti-D immunoglobulin · Biopharma Plasma LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rhesoglobin (human anti-D immunoglobulin), covering 2024-04-18 to 2024-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women [Phase 4]

See pricing